Patient demographics and baseline characteristics in the PLANETAS extension study (ITT population)
| Variable* | Maintenance group† (n=88) | Switch group‡ (n=86) |
|---|---|---|
| Age, years | 35.5 (18–69) | 39.0 (18–66) |
| Gender, n (%) | ||
| Male | 68 (77.3) | 74 (86.0) |
| Female | 20 (22.7) | 12 (14.0) |
| Ethnicity, n (%) | ||
| Caucasian | 70 (79.5) | 61 (70.9) |
| Asian | 10 (11.4) | 11 (12.8) |
| Other | 8 (9.1) | 14 (16.3) |
| Height, cm | 172.3 (148.0–198.0) | 172.2 (147.0–191.0) |
| Weight, kg | 72.0 (45.0–120.0) | 76.8 (45.5–122.7) |
| Body mass index, kg/m2 | 24.4 (18.0–38.7) | 26.3 (18.2–42.0) |
| ASDAS-CRP, mean (SD) | 3.86 (0.84) | 3.85 (1.09) |
| BASDAI score, n (%) | ||
| <8 | 65 (73.9) | 69 (80.2) |
| ≥8 | 23 (26.1) | 17 (19.8) |
Data shown were recorded at the baseline visit of the preceding 54-week, randomised, parallel-group study.
*Except where indicated otherwise, values are median (range).
†Patients treated with CT-P13 during the 54 weeks of the main study and the 48-week extension study.
‡Patients treated with RP during the 54 weeks of the main study and then switched to CT-P13 during the 48-week extension study.
ASDAS, Ankylosing Spondylitis Disease Activity Score; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CRP, C reactive protein; ITT, intent-to-treat; RP, reference product.